Cite
HARVARD Citation
Raubenheimer, P. et al. (2022). Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Diabetes, obesity & metabolism. 24 (4), pp. 704-712. [Online].